Samsung Biologics begins construction of world’s largest biopharmaceutical manufacturing facility

Nov 18, 2020

Samsung Biologics began construction of the world’s largest biopharmaceutical manufacturing facility in Incheon, South Korea. The plant is expected to commence operations by the end of 2022, and to be fully operational from 2023.

Print Page Mail Article